Efficacy and safety of a microsomal triglyceride transfer protein inhibitor in patients with homozygous familial hypercholesterolaemia: a single-arm, open-label, phase 3 study (Q36104706)
scientific article published on November 2, 2012
Language:
(P31) (Q13442814)
(P50) (Q58046422)
(Q57000993)
(Q42752751)
(Q39722638)
(Q56255391)
(P304) 40-46
(P407) (Q1860)
(P433) 9860
(P478) 381
(P577) Friday, November 2, 2012
(P921) (Q762713)
(Q1268941)
(Q186319)
(Q114049690)
(P953) https://europepmc.org/articles/pmc4587657?pdf=render
https://europepmc.org/articles/PMC4587657
https://europepmc.org/articles/PMC4587657?pdf=render
https://doi.org/10.1016/s0140-6736(12)61731-0
https://api.elsevier.com/content/article/PII:S0140673612617310?httpAccept=text/xml
https://api.elsevier.com/content/article/PII:S0140673612617310?httpAccept=text/plain
(P1433) (Q939416)
(P1476) "Efficacy and safety of a microsomal triglyceride transfer protein inhibitor in patients with homozygous familial hypercholesterolaemia: a single-arm, open-label, phase 3 study" (language: en)
(P2093) Marina Cuchel
Hendrik du Toit Theron
Daniel Gaudet
Claudia Stefanutti
Phase 3 HoFH Lomitapide Study investigators
Emma A. Meagher
A. David Marais
Maurizio R. Averna
Cesare R. Sirtori
Prediman K. Shah
Anna M. E. Du Plessis
Kathleen J. Propert
William J. Sasiela
LeAnne T. Bloedon
(P2860) (Q37799233)
(Q37789441)
(Q34991553)
(Q33386394)
(Q37304815)
(Q28282776)
(Q35806357)
(Q24672834)
(Q35025129)
(Q27863447)
(Q34291627)
(Q42545652)
(Q46408437)
(Q43130496)
(Q42647881)
(Q46573174)
(Q46603544)
(Q46478476)
(Q44009231)
(Q64040523)
(Q77449866)
(Q73901930)
(Q83153148)
other details
description scientific article published on November 2, 2012

External Links